Leukemia Research
Volume 26, Issue 3 , Pages 281-288 , March 2002

Improvement of combination chemotherapy tolerance by introduction of polycistronic retroviral vector drug resistance genes MGMT and MDR1 into human umbilical cord blood CD34+ cells

  • Jishi Wang

      Affiliations

    • Jiangsu Institute of Hematology, First Affiliated Hospital of Suzhou University, Suzhou 215006, People's Republic of China
    • Department of Hematology, Affiliated Hospital of Guiyang Medical College, Guiyang 550004, People's Republic of China
    • Corresponding Author InformationCorresponding author. Present address: Department of Phar. (Lab #5301), New York Medical College, Valharla, NY 10595, USA
    • ,
  • Zixing Chen

      Affiliations

    • Jiangsu Institute of Hematology, First Affiliated Hospital of Suzhou University, Suzhou 215006, People's Republic of China
    • ,
  • Xueming Xia

      Affiliations

    • Jiangsu Institute of Hematology, First Affiliated Hospital of Suzhou University, Suzhou 215006, People's Republic of China
    • ,
  • Daru Lu

      Affiliations

    • Institute of Genetics, Fudan University, Shanghai 200433, People's Republic of China
    • ,
  • Jingluen Xue

      Affiliations

    • Institute of Genetics, Fudan University, Shanghai 200433, People's Republic of China
    • ,
  • Changgeng Ruan

      Affiliations

    • Jiangsu Institute of Hematology, First Affiliated Hospital of Suzhou University, Suzhou 215006, People's Republic of China

Received 28 November 2000 ,Accepted 29 May 2001.

References 

  1. Galipeau J, Benaim E, Spencer HT, Blakely RL, Sorrentino BP. A bicistronic retroviral vector for protecting hematopoietic cells against anlifolates and P-glycoprotein effluxed drugs. Hum. Gene Ther. 1997;8:1773–1783
  2. Hesdorffer C, Ayello J, Ward M, Kaubisch A, Vahdat L, Balmaceda C, et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J. Clin. Oncol. 1998;16:165–172
  3. Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, et al. Paclitaxel chemo-therapy after autologous stem-cell transplantation and engraftment of hemato-poietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin. Cancer Res. 1999;5:1619–1628
  4. Licht T, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice. Gene Ther. 2000;7:348–358
  5. Moscow JA, Huang H, Carter C, Hines K, Zujewski J, Cusack G, et al. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood. 1999;94:52–61
  6. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood and adult marrow. Exp. Hematol. 1999;27:1418–1427
  7. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, et al.  Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc. Natl. Acad. Sci. USA. 1992;89:4109–4113
  8. Huang S, Law P, Young D, Ho AD. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Exp. Hematol. 1998;26:1162–1171
  9. Weekx SF, Van Bockstaele DR, Plum J, Moulijn A, Rodrigus I, Lardon F, et al. Snoeck HWCD34++ CD38− and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp. Hematol. 1998;26:1034–1042
  10. Cardoso AA, Li ML, Batard P, Hatzfeld A, Brown EL, Levesque JP, et al. Release from quiescence of CD34+ CD38− human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Natl. Acad. Sci. USA. 1993;90:8707–8711
  11. Gerson SL, Phillips W, Kastan M, Dumenco LL, Donovan C. Human alkylguanine-DNA alkyltransferase and are sensitive to O6-benzyl-guanine plus BCNU. Blood. 1996;88:1649–1655
  12. Qiu L, Meagher R, Welhausen S, Heye M, Brown R, Herzig RH. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J. Hematother. Stem Cell Res. 1999;8:609–618
  13. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood. 1998;91:3487–3493
  14. Michael FL, Debabrata BE, Leonard JP, et al.  Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. Hum. Gene Ther. 1998;9:63–71
  15. Allay J, Persons DA, Galipeau J, et al.  Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hemato-poietic cells. Stem Cells. 1998;16:223–233
  16. Devereux S, Corney C, Macdonald C, Watts M, Sullivan A, Goldstone AH, et al. Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma. Gene Ther. 1998;5(3):403–408
  17. Tano K, Shiota S, Collier J, et al.  Isolation and structural characterization of a cDNA clone coding the human DNA repair protein for O6-alklguanine. Proc. Natl. Acad. Sci. USA. 1990;87:686–690
  18. Allay JA, Davis BM, Gerson SL. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Exp. Hematol. 1997;25:1069–1076
  19. Jishi Wang, Xueming Xia, Zixing Chen, Changgen Ruan. In vitro study on the cloning and transduction of human O6-methylguanine-DNA-methyltransferase cDNA into human umbilical cord blood CD34+ cells. Chin. J. Cancer Res. 2000;12:115–119
  20. Allay JA, Dumenco LL, Koc ON, Liu L, Gerson SL. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood. 1995;85:3342
  21. Moritz T, Mackay W, Glassner BJ, Williams DA, Samson L. Retrovirus-mediated expression of a DNA repair pair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res. 1995;55:2608–2613
  22. Bearzatto A, Szadkowski M, Macpherson P, Jiricny J, Karran P. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res. 2000;15:3262–3270
  23. Hickson I, Fairbairn LJ, Chinnasamy N, Lashford LS, Thatcher N, Margison GP, et al. Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNAalkyltransrerase attenuates the toxic effects of O6-alkylating agents in vitro. Gene Ther. 1998;5:835–841
  24. Chinnasamy N, Rafferty JA, Hickson I, Lashford LS, Longhurst SJ, Thatcher N, et al. Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase. Gene Ther. 1998;5:842–847
  25. Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T. Retroviral co-expression of two different types of drug resistance genes to protect normal cells from combination chemotherapy. Clin. Cancer Res. 1997;3:947–954
  26. Wang Jishi, Xia Xueming, Chen Zixing, Lu Daru, Xue Jinglun, Ruan Changgeng. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance. Chin. Med. J. 2001;114:25–29
  27. Aran JM, Licht T, Gottesman MM, Pastan I. Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy. Hum. Gene Ther. 1996;7:2165–2175
  28. Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T. Retroviral co-expression of two different types of drug resistance genes to protect normal cells from combination chemotherapy. Clin. Cancer Res. 1997;3:947–954
  29. Lynch CM, Miller AD. Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J. Virol. 1991;65:3887–3890
  30. Chong H, Starkey W, Vile RG. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs and endogenous retroviral sequences. J. Virol. 1998;72:2663–2670
  31. Bechtel MK, Hayes KA, Mathes LE, Pandey R, Stromberg PC, Roy-Burman . Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus. Vet. Pathol. 1999;36:91–99
  32. Beausejour CM, Le NL, Letourneau S, Cournoyer D, Momparler RL, Christian M, et al.  Co-expression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate. Hum. Gene Ther. 1998;9:2537–2544
  33. Allay JA, Koc ON, Davis BM, Gerson SL. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors. Clin. Cancer Res. 1996;2:1353–1359
  34. Kleiman SE, Pastan I, Puck JM, Gottesman MM. Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiency. Gene Ther. 1998;5:671–676
  35. Moreb JS, Schweder M, Gray B, Zucali J, Zori R. In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclo-phosphamide. Hum. Gene Ther. 1998;9:611–619
  36. Suzuki M, Sugimoto Y, Tsuruo T. Efficient protection of cells from the genotoxicity of nitrosoureas by the retrovirus-mediated transfer of human O6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1. Mutat. Res. 1998;401(1–2):133–141
  37. Flasshove M, Banerhee D, Banerjee D, Mineishi S, Li MX, Bertino JR, et al. Ex vivo expansion and selection of human CD34− positive peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood. 1995;85:566
  38. Koc ON, Reese JS, Davis BM, Liu L, Majczenko KJ, Gerson SL. ΔMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chlorotthy1)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-choroethyl-1-nitroaourea-resistant human colon cancer xenografts. Hum. Gene Ther. 1999;10:1021–1030
  39. Maze R, Kapur R, Kelley MR, Hansen WK, Oh SY, Williams DA. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA. J. Immunol. 1997;158:1006–1013
  40. Liu Lili, Lee Keunmyoung, Schuopp Jane, et al.  Heterogeneity of O6-alklguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells. Clin. Cancer Res. 1998;4:475–481

PII: S0145-2126(01)00111-4

Leukemia Research
Volume 26, Issue 3 , Pages 281-288 , March 2002

Article Tools

* Image Usage & Resolution